The present study investigated the possible involvement of the nucleus accumbens' (NAc) nitric oxide system in nicotine's reversal effect upon ethanol-induced amnesia. The hypothesis was tested through ethanol state-dependent memory assessment in adult male Wistar rats. Bilateral chronic cannulae were implanted in the NAc and the animals were trained in a step-through type inhibitory avoidance memory task. The step-through latency was examined 24 h after animals' training. The pre-training or pre-test intraperitoneal (i.p.) injection of ethanol (0.9 g/kg) decreased the step-through latency, indicating an amnesic effect of the drug. Meanwhile, the pre-test administration of ethanol (0.6 and 0.9 g/kg) could reverse the pre-training ethanol (0.9 g/kg)-induced amnesia, suggesting a state-dependent effect. Similar to ethanol, the pre-test intra-NAc microinjection of nicotine (0.25 and 0.5 µg/rat) alone or nicotine (0.1, 0.25 and 0.5 µg/mouse, intra-NAc) in combination with an ineffective dose of ethanol (0.3 g/kg) could significantly reverse the (pre-training) ethanol-induced memory impairment. The ethanol (0.9 g/kg)-induced amnesia was similarly prevented following the pre-test intra-NAc administration of a nitric oxide synthase (NOS) inhibitor, L-NAME (0.4 and 0.8 µg/rat). Of note, the co-administration of L-NAME (0.04 and 0.08 µg/rat, intra-NAc) with an ineffective dose of nicotine (0.1 µg/rat, intra-NAc) could significantly potentiate the memoryimproving effect of nicotine on ethanol-induced amnesia and resembled the effects of pretest administration of a higher dose of nicotine. Furthermore, while the pre-test intra-NAc injection of L-NAME impaired the memory retrieval by itself, the pre-test intra-NAc administration of L-arginine, a nitric oxide precursor (0.3 and 0.6 µg/rat, intra-NAc), did not exert any effect either alone or in combination with an effective dose of nicotine (0.5 µg/rat, intra-NAc) on pre-training ethanol-induced memory impairment. Our findings indicated a possible role of the nucleus accumbens' nitric oxide system in the improving effects of nicotine on ethanol-induced amnesia and the related state-dependent learning.
Introduction
Cigarette smoking is often accompanied by the use of ethanol (1, 2) . Both ethanol and nicotine can potentially activate the mesolimbic dopaminergic system projecting from the ventral tegmental area to the nucleus accumbens, hippocampus, amygdala and the prefrontal cortex. These drugs have therefore an important role in reward and rewardrelated learning (3) .The impairing effects of ethanol on learning and memory have been well-established in different experimental models (4) (5) (6) including the inhibitory avoidance (7, 8) , working (9) and spatial memory (10) (11) (12) . In agreement with some earlier reports (4, 13, 14) , we noticed that ethanol, when administered both pre-and post-training, can impair inhibitory avoidance memory in a state-dependent manner, and the effect is reversible by pre-test ethanol treatment. A considerable body of evidence suggests a solid interaction between ethanol and nicotine in the central nervous system (Collins et al. 1993 (Collins et al. , 1996 Smith et al. 1999; Lê et al. 2003) in which the nicotinic acetylcholine receptors seem to have an important role for such interrelation (3, 15, 16) .Former reports have indicated that the combination of alcohol and nicotine may produce state-dependent learning in humans (17) . In addition, according to some later studies, the administration of nicotinic receptor agonists reversed the ethanol-induced amnesia in laboratory animals (7, (18) (19) (20) .While nicotine may reverse the ethanol-induced amnesia (similar to pre-test ethanol), the drugs have some opposite effects on other cognitive functions (6, 8, 21) . Where nicotine enhances learning either through a direct effect on attention or affecting the pre-synaptic nicotinic acetylcholine receptors, ethanol may potentially impair learning (4) (5) (6) . Taken together, the opposite effects of ethanol and nicotine on cognitive functions (5, 8, 21) have made the interaction between them complex and hence not fully understood yet.
On the other hand, there exist some welldemonstrated interactions between nicotine and NO (22) (23) (24) . Cumulating evidence has supported the hypothesis that some behavioral effects of nicotine and ethanol are mediated by NO (6, 23, 25) . For instance, the inhibition of NOS has been reported to attenuate various nicotine-induced addictive behaviors including the dependence (26), sensitization (22) , withdrawal (27) and reward (28). The dorsal hippocampal NO system has also been shown to play an important role in ethanol statedependent learning (6) . According to one of our recent reports, the intra-CA1 injection of nicotine restores the ethanol-induced amnesia, at least partly through the activation of the NO system in the dorsal hippocampus (7) . Our data substantiated that the intra-CA1 microinjection of L-arginine potentiates the reversal effect of nicotine on ethanol-induced amnesia, while the intra-CA1 administration of L-NAME prevented the improving effect of nicotine on the same(7). Findings from a large body of research have suggested the modulatory effects of NO on different learning and memory processes, namely the inhibitory avoidance memory(29-32) and spatial learning (33-36). For example, systemic, intra cerebro-ventricular(i.c.v.) or local injection of NOS inhibitor, has led to impairments in object recognition (37), spatial learning (30, 38)and inhibitory avoidance (30, 39-41) tasks in rats. Moreover, NOS inhibitors are shown to potentially impair the memory performance in one-trial inhibitory avoidance (7)and spontaneous alternations in mice (36). Other studies, however, have shown no effects of NOS inhibition on learning and memory processes. According to Blokland et al. (42) and Bannerman et al. (43), the systemic or intra-hippocampal injections of NOS inhibitors did not impair the spatial learning. Bohme et al. also reported that L-NAME administration produces no significant effect on inhibitory avoidance memory in rats (44).
It has been proposed that the inhibitory avoidance paradigm, which is widely used in pharmacological studies on long term memory in rodents, mainly involves the dorsal hippocampus (45).However, the hippocampal memory processes are largely affected by several limbic nuclei such as the NAc and VTA (46). Recent investigations have suggested a functional loop between the hippocampus, NAc and VTA, which controls the entry of information into long-term memory. The upward arc of this loop comprises dopaminergic neurons projecting from the VTA to hippocampus and the downward arc includes the NAc and ventral pallidum (VP)(46). The VTA dopamine neuron activity can receive accumbal influence both though direct projections to the VTA and an indirect projection via the VP (47). These projections are shown to be GABA ergic pathways (48, 49) .Based on some solid evidence, NOS is localized in the somata and dendrites of these GABAergic neurons which typically project from the nucleus accumbens (NAc) to the ventral tegmental area (VTA) (50, 51) .Since such GABAergic neurons comprise almost 90% of the neuronal population in the NAc (52, 53) , the downward arc of the aforementioned functional-loop may serve as an inhibitory control over the activity of VTA dopaminergic neurons.
Previous studies have demonstrated the dopaminergic system's critical role in the reversal effect of nicotine on amnesia induced by ethanol or morphine (54, 55) . It is therefore possible that NO agents influence the reversal effect of nicotine on ethanol-induced amnesia via the modulation of the GABAergic neurons, projecting from the NAc to VTA.
Based on our earlier investigation, the dorsal hippocampal NO system seems to be involved in the improving effect of nicotine on ethanol-induced amnesia (7) . Meanwhile, the involvement of accumbal NO system in the effect of nicotine on ethanol-induced amnesia cannot be excluded. Considering the presence of NOS in the NAc as well as the well-discussed interactions between NO system and nicotine or ethanol effects (24, 56, 57), the aim of the present research was to investigate the role of NO system of the NAc in the reversal effect of nicotine upon ethanol-induced memory impairment in rats.
Materials and methods

-Animals
Adult male Wistar rats (Pasteur institute, Tehran, Iran) weighing 220-270 g at the time of surgery were used. Animals were housed four per cage with access to food and water ad libitum and kept at (22 ± 2) •C under a 12/12 h light-dark cycle (lights on at 7:00 AM). All experiments were done during the light phase between 8:00 and 14:00. Each experimental group comprised eight animals and each animal was tested only once. Behavioral tests and animal care were conducted in accordance with the standard ethical guidelines (NIH, publication no. 85-23, revised 1985 ; European Communities Directive 86/609/EEC) and approved by the local ethical committee.
-Surgery Animals were anesthetized using the intraperitoneal (i.p.)ketamine/ xylazine mixture (50 mg/kg ketamine, 5 mg/kg xylazine) and placed in a stereotaxic frame (David Kopf Instruments) in a flatskull position [incisor bar -3.3 mm] relative to the inter-aural line (58) . A midline incision was made with the skin and underlying periosteum retracted. Bilateral stainless steel guide cannulae (22 gauge) were implanted 2 mm above the NAc shell according to stereotaxic coordinates including AP:+1 mm forward of bregma, L: ± 1 mm from midline, V: -5.5 mm relative to dura (58) , and anchored to the skull with dental cement. Stainless steel stylets (27 gauge) were inserted into the guide cannulae to maintain the patency. All animals were allowed one week to recover from surgery.
-Drugs and microinjections
The applied drugs were ETOH (Merck, Germany), L-NAME (NG-nitro-L-arginine methyl ester, a nonspecific inhibitor of nitric oxide synthase), L-arginine (Sigma, St Louis, CA, USA) and nicotine hydrogen tartrate (Sigma, Poole, Dorset, UK). All drugs were dissolved in sterile saline except nicotine which was dissolved in sterile saline with the pH of the solution adjusted to 7.2 with NaOH (0.1 normal solution). The 1 g/kg dose of ethanol was made from a 12.6% ethanol in 0.9% saline (vol/vol) stock solution, made freshly for each experiment and then diluted to the required concentration (0.5 g/kg). Ethanol was injected i.p. at a volume of 1 ml/kg. Bilateral intra-NAc micro-infusions of L-arginine and L-NAME were at a volume of 0.6 µl (0.3 µl/side). To administer the intra-NAc doses, the 27-gauge infusion cannulae were lowered to extend 2 mm beyond the tip of the guide cannulae at the infusion sites. The infusion cannula was attached to a 1 µl Hamilton syringe via a polyethylene tubing. Infusions (0.3µl/side) were made over 60 s, first on one side then the other, and the infusion cannulae were left in place for an additional 30 s to facilitate drug diffusion. Control animals received either saline or vehicle. In experiments where animals received one or two injections, the control groups received one or two saline or vehicle injections. The timing between injections and the injection sequence were defined based on a pilot study and our previous findings (7, 40, 41, 59, 60).
-Inhibitory avoidance apparatus
We used a step-through inhibitory avoidance apparatus consisting of two same-size compartments (20 × 20 × 30 cm3). A manually retractable guillotine door (7.9 cm2) isolated the two compartments at the middle of a dividing wall. The walls and the floor of one compartment were composed of white opaque resin and the walls of the other compartment were dark. Stainless steel bars (0.3 mm in diameter set in 1 cm intervals) constituted the floor of the dark compartment. Intermittent electric shocks (50 Hz, 3 s, and 1 mA intensity) were delivered to the grid floor of the dark compartment by an isolated stimulator.
-Behavioral procedures
Training was done based on our previous studies (61, 62) . All animals were allowed to habituate in the experimental room for at least 30 min prior to the experiments. Each animal was then gently placed in the brightly lit compartment of the apparatus. After 5 s, the guillotine door was opened and the animal was allowed to enter the dark compartment. The latency after which the animal crossed into the dark compartment was recorded. Animals which spend over 100 s to cross to the dark compartment were eliminated from the experiments. Once the animal crossed (with all four paws) to the next compartment, the guillotine door was closed and the rat was taken into its home cage. The trial was repeated after 30 min. Similar to the acquisition trial, the guillotine door was opened in 5 s and as soon as the animal crossed to the dark (shock) compartment the door was closed and a foot shock (50 Hz, 1 mA and3 s) was immediately delivered to the grid floor of the dark room. After 20 s, the rat was removed from the apparatus and temporarily placed into its home cage. Two minutes later, the procedure was repeated. In case the rat avoided entering the dark compartment within 120 s, a successful acquisition of inhibitory avoidance response was recorded. On the other hand, when the rat entered the dark compartment (within120 s) a second time, the door was closed and the animal received the same shock again. Twenty-four hours after training, each animal was gently placed in the light compartment for 20 s, the door was opened, and the step-through latency was measured for entering into the dark compartment. The testing session was ended once the animal entered the dark compartment or remained in the light compartment for 300 s (criterion for retrieval). During testing sessions, no electric shock was applied.
Experimental design
Experiment 1: In this experiment, the effect of pretraining and pre-test administration of ethanol on inhibitory avoidance response was examined in eight groups (n=8/group). Two groups received pretraining saline (1 ml/kg), others received either saline or ethanol (0.9 g/kg) before testing (pre-test) as control groups. The remaining three groups of animals received different doses (0.3, 0.6 and 0.9 g/kg, i. This experiment examined the effects of pre-test administration of nicotine alone or in combination with ethanol on ethanol-induced amnesia in twelve groups (n=8/group). Four groups of animals received pre-training saline (1 ml/kg, i.p.). On the test day, animals of these groups received saline (1 ml/kg) 30 min before testing plus different doses of nicotine (0, 0.1, 0.25 and 0.5 μg/rat, intra-NAc ) 5 min prior to the test. Other eight groups received pre-training ethanol (0.9 g/kg). During the test day, four groups of these animals received saline (1 ml/kg) 30 min before testing plus different doses of nicotine (0, 0.1, 0.25 and 0.5 μg/rat, intra-NAc), 5 min before testing. The other four groups received ethanol (0.3 g/kg) 30 min before testing plus different doses of nicotine (0, 0.1, 0.25 and 0.5 μg/rat, intra-NAc), 5 min prior to the test (Fig. 2) . In this experiment, we assessed the effects of pre-test administration of L-NAME alone or in combination with ethanol on ethanol-induced amnesia in twelve groups (n=8/group). Four groups of animals received pre-training saline (1 ml/kg). During the test day, these animals received L-NAME (0, 0.4, 0.8 and 0.16 μg/rat, intra-NAc) and were injected with vehicle (0.6 μ1/rat, intra-NAc), 5 min later.Other eight groups of animals received a pretraining effective dose of ethanol (0.9 g/kg). Upon test, four groups of these animals received L-NAME (0, 0.4, 0.8 and 1.6 μg/rat, intra-NAc) and were similarly injected with vehicle (0.6 μ1/rat, intraNAc),5 min later. The other four groups of animals received L-NAME (0, 0.4, 0.8 and 1.6 μg/rat, intraNAc) and in 5 min, were injected with nicotine (0.1 μg/rat, intra-NAc).
Step-through latency was measured 5 min after the last injection (Figure 3) . Figure 3 . The effects of pre-test intra-NAc microinjection of L-NAME in the presence or absence of ethanol and/or nicotine on memory retrieval.
Experiment 4: we examined the effects of pre-test administration of L-arginine alone or in combination with nicotine on ethanol-induced amnesia in this experiment. The experiment included eight groups of animals (n=8/group) of which four groups received pre-training saline (1 ml/kg). During the test day, animals in these four groups received Larginine (0, 0.15, 0.3 and 0.6 μg/rat, intra-NAc) and were injected with vehicle (0.6 μ1/rat, intra-NAc), 5 min later. The remaining four groups received a pretraining effective dose of ethanol (0.9 g/kg). On the test day, these animals received L-arginine (0, 0.15, 0.3 and 0.6 μg/rat, intra-NAc) and after 5 min, they were similarly injected with an effective dose of nicotine (0.5 μg/rat, intra-NAc).
Step-through latency was measured 5 min after the last injection (Figure 4 ). Following the testing sessions, each rat was deeply anesthetized and 0.6 µl of a 4% methyleneblue solution was bilaterally infused into the NAc (0.3 µl/ side), as described in the drug section. Each animal was then decapitated with its brain removed and placed in formaldehyde (10%). After several days, the fixated brains were sliced and the sites of injections were verified according to the rat brain atlas by Paxinos and Watson (58) . Although cannulae were implanted into the NAc of a total of 350 animals, only the data from 320 animals with correct cannulae implants were included in the statistical analyses.
-Data analysis
The data are expressed as mean ± S.E.M. The statistical analysis was performed using one-way and two-way analysis of variance (ANOVA). Post-hoc comparison of means was carried out using Tukey's test for multiple comparisons, when appropriate. The level of statistical significance was set at P<0.05. Calculations were performed using the SPSS statistical package. Figure 1 shows the effects of pre-training or pretest administration of ethanol on step-through latency. One-way ANOVA revealed that pre-training or pre-test ethanol (0.9 g/kg, i.p.) impaired inhibitory avoidance memory on the test day, as compared to the saline-treated animals [F (4, 35) = 29.01, P<0.001]. In other groups, the pre-test ethanol administration (0.6 and 0.9 g/kg, i.p.) reversed the pre-training ethanol-induced amnesia (0.9 g/kg, i.p.) [F (3, 28) = 17.19, P<0.001].
Results
-The effects of ethanol on inhibitory avoidance memory
-The effects of pre-test nicotine administration with or without ethanol on inhibitory avoidance memory Figure 2 illustrates the effects of pre-test injection of nicotine in the presence or absence of ethanol on inhibitory avoidance memory. Two-way ANOVA results showed an interaction between the groups of animals with pre-training saline (1 ml/kg) and pre-test nicotine treatment (0.1, 0.25 and 0.5 μg/rat, intra-NAc) and those with pre-training ethanol (0.9 g/kg, i. (Fig. 2, left panel) . Where the pre-training administration of ethanol (0.9 g/kg) impaired inhibitory avoidance memory, the intra-NAc administration of nicotine (0.25 and 0.5 μg/rat), on the test day, significantly reversed the ethanol-induced amnesia [F (3, 28) = 38.73, P<0.001] (Fig.  2, middle panel) . Although the lower dose of the pretest ethanol (0.3 g/kg) alone did not induce a significant ethanol state-dependent memory, the co-administration of different doses of nicotine (0.1, 0.25 and 0.5 μg/rat, intra-NAc) with 0.3 g/kg of ethanol significantly improved the memory retrieval and resembled the effects of pre-test administration of a higher dose ethanol [F(3,28)= 50.87, P<0.001] (Figure 2, right panel) .
-The effects of pre-test administration of L-NAME alone or in combination with nicotine on ethanol-induced amnesia
The effects of pre-test intra-NAc microinjection of L-NAME in the presence or absence of ethanol and/or nicotine on memory retrieval has been demonstrated in Fig.3 . Two-way ANOVA revealed an interaction between the groups of animals with pretraining saline (1 ml/kg) and pre-test L-NAME treatment (0, 0.04, 0.08 and 0.16 μg/rat, intraNAc) and those which were treated with pre-training ethanol (0.9 g/kg, i.p.) and pre-test L-NAME [for Treatment, F(1,56)= 0.61, P>0.05; Dose, F(3,56)= 2.34, P>0.05; and Treatment ×Dose interaction, F(3,56)= 16.13, P<0.001] for their inhibitory avoidance memory. Two-way ANOVA also indicated a significant difference between the groups of animals which received pre-training saline (1 ml/kg) and pre-test L-NAME and those which received pretraining ethanol (0.9 g/kg, i.p.), followed by pre-test a lower dose of nicotine (0.1 μg/rat, intra-NAc) plus L-NAME [for Treatment, F(1,56)= 9.42, P<0.01; Dose, F(3,56)= 7.91, P<0.001; and Treatment ×Dose interaction, F(3,56)= 24.65, P<0.001] for their inhibitory avoidance memory. In addition, twoway ANOVA results showed a significant difference between the groups of animals which received pretraining ethanol (0.9 g/kg, i.p.) and pre-test L-NAME and those which received pre-training ethanol (0.9 g/kg, i.p.), followed by pre-test a lower dose of nicotine (0.1 μg/rat, intra-NAc) plus L-NAME [for Treatment, F(1,56)= 9.88, P<0.01; Dose, F(3,56)= 9.55, P<0.001; and Treatment ×Dose interaction, F(3,56)= 11.01, P<0.001] with regard to their inhibitory avoidance memory. Moreover, based on the post hoc analysis, the pre-test intra-NAc administration of L-NAME (0, 0.04, 0.08 and 0.16 μg/rat) reduced the step-through latency in the inhibitory avoidance task and appeared to induced amnesia [F(3, 28)= 15.93, P<0.001] (Fig. 3, left  panel) . Where the pre-training administration of ethanol (0.9 g/kg) impaired memory, administration of a higher dose of L-NAME (0.16 μg/rat, intra-NAc), on the test day, significantly reversed the ethanolinduced amnesia [F (3, 28) = 5.51, P<0.01] (Fig. 3,  middle panel) . Besides, the co-administration of L-NAME (0.04 and 0.08 μg/rat, intra-NAc) with 0.1 μg/rat of nicotine significantly potentiated the reversal effect of nicotine on ethanol-induced amnesia and mimicked the effects of the pre-test administration of a higher dose of ethanol or nicotine [F(3, 28)= 16.53, P<0.001] , (Figure 3 , right panel).
-The effects of pre-test administration of L-arginine alone or in combination with nicotine on ethanol-induced amnesia Figure 4 illustrates the effect of pre-test intra-NAc administration of L-arginine in the presence or absence of ethanol and nicotine on inhibitory avoidance memory. Two-way ANOVA indicated a significant difference between the effects of Larginine (0, 0.15, 0.3 and 0.6 μg/rat, intra-NAc) alone and L-arginine plus nicotine (0.5 mg/kg) on inhibitory avoidance memory [for Treatment, F (1, 56) = 15.92, P<0.001; Dose, F (3, 56) = 8.64, P <0.001; and Treatment ×Dose interaction, F (3, 56) = 6.18, P<0.001]. One-way ANOVA also revealed that in the animals which were trained before saline treatment and tested following the intra-NAc administration of different doses of L-arginine (0.15, 0.3 and 0.6 μg/rat, intra-NAc), no significant change was observed in the retrieval latencies [F (3, 28) =0.37, P>0.05]. Furthermore, where pretraining administration of ethanol (0.9 g/kg) impaired inhibitory avoidance memory, the pre-test intra-NAc microinjection of L-arginine (0.3 and 0.6 μg/rat) could prevent the reversal effect of nicotine (0.5 μg/rat) on ethanol-induced amnesia [F (3, 28) = 13.59, P<0.001] (Figure 4, right panel) .
Discussion
This study investigated the role of NAc NO system in the reversal effect of nicotine on ethanol-induced amnesia and ethanol state-dependent memory. While many reports have suggested the dorsal hippocampus as the main site for modulation of memory (59, 63) , accumulating evidence have proposed that NAc or other sites of the brain may be involved in memory processes (7) . According to the present data, the pre-training or pre-test injection of ethanol could decrease the step-through latency in a dose-dependent manner when animals were tested following 24 h. Other investigations have similarly shown that the pre-training ethanol inhibits the acquisition of memory in different paradigms such as inhibitory avoidance (7, 8) , working (9) and spatial memory (10) (11) (12) .Our findings also showed that administration of the same dose of ethanol before retention, reverses the ethanol-induced amnesia. This phenomenon, called ethanol statedependent learning, has previously been studied in our laboratory (6) (7) (8) and by others as well. Studies have proposed that the acquired information in one drug state is better remembered when the retrieval is tested in the same drug state (7, 8, 41, 64, 65) .
According to our findings, the pre-test intra-NAc microinjection of nicotine reversed the memory impairment induced by pre-training systemic injection of ethanol. At the same time, , the coadministration of an ineffective dose of ethanol with a lower dose of nicotine before retention, significantly reversed the ethanol-induced amnesia and mimicked the effects of pre-test administration of a higher dose of ethanol or nicotine. In support of such findings, we have recently reported that the intra-CA1 (dorsal hippocampal) pre-test injection of nicotine is able to restore ethanol-induced amnesia in mice (5, 7, 8) . Evidence has shown that the amnesic effects of ethanol on both reference and working memory can be blocked by nicotine pretreatment (20) . The present data also are in agreement with those from other investigations, indicating an interaction between ethanol and central nicotinic receptors, both in vivo (3, 66, 67) and within neuronal cultures (68) .
Both ethanol and nicotine increase the dopamine release in the NAc(3). The dopamine pathway may not be the only pathway accountable for the reversal effect of nicotine on memory and other neurotransmitter mechanisms may also be involved therein. Many of nicotine effects are possibly due to the ability of the drug to release various neurotransmitters (69) . It has been postulated that stimulation of nicotinic receptors enhances the release of glutamate and NO production both in the VTA and NAc (70) . Considering the functional interactions of ethanol and nicotine with NO (7, 40, 41) and that the NAc is a key structure in learning and memory (41, 65), we strived to examine the role of NO systems in the NAc in the reversal effect of nicotine on ethanol-induced amnesia. Our findings showed that the pre-test intra-NAc administration of L-NAME, but not L-arginine, impairs the inhibitory avoidance memory by itself. Such results are in line with other evidence indicating that the systemic, intra-CA1, intra-VTA or intra-NAc injection of L-NAME impairs memory (6, 7, 40, 41, (71) (72) (73) (74) .
Our data also demonstrated that the pre-test intraNAc injection of L-NAME reverses the ethanolinduced amnesia. Likewise, the pre-test injection of an ineffective dose of nicotine in combination with the lower doses of L-NAME, which had no effect alone, synergistically restored the ethanol-induced amnesia. The above results may propose an interaction between the NO system and reversal effects of nicotine in the NAc upon restoring the ethanol-induced memory impairment. Along these lines, our previous studies have revealed that NO system and NMDA receptors of dorsal hippocampus involve in the reversal effect of nicotine on ethanolinduced amnesia (5, 7). Our earlier findings also indicated that NO system and NMDA receptors of the NAc involve in the reversal effect of nicotine on morphine amnesia(41, 65).The NAc can influence dopamine neuronal activity originating from the VTA (75) . The medium spiny neurons, which project from the NAc to the VTA, are GABAergic (52, 53) . Therefore, activation of theses spiny neurons can inhibit the VTA dopaminergic neurons. Convergent evidence indicates that NMDA receptors and NOS are expressed in the somata and dendrites of these GABAergic neurons (50, 51) . Therefore, it is possible that theL-NAME-related inhibition of NO system in the NAc increases dopamine release from the VTA, which may in turn modulate memory processes in the hippocampus and other target areas.
We have already reported that the intra-NAc injection of the NMDA receptor antagonist (MK-801) or NOS inhibitors (L-NAME) potentiates the reversal effect of nicotine on morphine-induced amnesia (41, 65). It has then been proposed that the blockade of GABAergic neurons (projecting from NAc to VTA)using MK-801 (65) or L-NAME (41) activates of VTA dopaminergic neurons and increases dopamine release in the NAc (76) (77) (78) (79) (80) . There are many reports highlighting the role of dopamine as a key mediator for learning and memory (81) (82) (83) . Evidence also indicates that dopamine mediates motivational effects of nicotine (84) . As such, it seems possible that similar effects of nicotine and L-NAME on restoring ethanol-or morphine-induced amnesia during inhibitory avoidance memory task are modulated through the mesolimbic dopamine systems. Thus, an ineffective dose of nicotine plus lower doses of L-NAME, similar to an effective dose of nicotine or ethanol, seem to effectively activate the VTA dopaminergic neuron and restore the ethanol-induced amnesia. Meanwhile, further investigations are required to let this be fully understood. Another justification would be that the effects of a drug on memory retrieval, when given before retention test, simply depend on how well the information has been stored previously. As such, a drug which impairs the memory retrieval in animals with strong memory may enhance memory retrieval in animals with poor memory (53, 85) .
Based on the present report, the pre-test coadministration of L-arginine with an effective dose of nicotine blocked the reversal effect of nicotine on ethanol-induced amnesia. The results obtained by L-arginine injection may further support the hypothesis that the NAc NO system plays a key part in the reversal effect of nicotine on ethanol-induced amnesia. The effect of L-arginine may be due to the influence on GABAergic projections from the NAc to the VTA, which favors dopamine release. In contrast with the present data, our recent report showed that the pre-test intra-CA1 injection of L-arginine or ineffective doses of L-arginine plus an ineffective dose of nicotine can restore ethanol-induced amnesia, while the co-administration of L-NAME with an effective dose of nicotine before retention test, blocked the reversal effect of nicotine on ethanol-induced amnesia (7) . Such discrepancy in results could partly be explained by differences in the brain sites in which NO-related compounds were infused. It could be inferred from these results that the intra-CA1 injection of L-arginine, similar to nicotine, increases the dorsal hippocampal dopamine release. On the contrary, the intra-CA1 injection of L-NAME injection is shown to decrease the release of dopamine in the dorsal hippocampus (7) .Moreover, the intra-NAc injection of L-arginine is shown not only to inhibit the VTA dopaminergic neurons via the activation of NAc to VTA GABAergic projections but also to decrease dopamine release in the target area of mesolimbic dopamine pathway such as NAc and hippocampus. Meanwhile, the intra-NAc injection of L-NAME has been shown to activate the VTA dopaminergic neurons via the inhibition of descending GABAergic neurons projecting from NAc to VTA and increased the release of dopamine in the dorsal hippocampus (41, [76] [77] [78] [79] [80] .
Such an apparent discrepancy in the obtained results could at least be partly attributed to the neuromodulatory role of NO in different sites of the brain. Our present data are consistent with previous findings showing that the intra-NAc infusion of NMDA receptor antagonist or NOS inhibitors potentiate the reversal effect of nicotine on morphine-induced amnesia while the intra-NAc injection of NMDA or NO precursor block the reversal effect of nicotine on memory impairment induced by morphine pretreatment (41, 65).
Conclusion
In conclusion, the blockade or activation of the NO system of NAc potentiates or decreases the reversal effect of nicotine upon ethanol-induced amnesia, respectively.
